Am J Transplant, Volume 16, Suppl 3 Archives - Page 145 of 180 - ATC Abstracts

2016 American Transplant Congress
Risk Factors for Early vs. Late Onset Clostridium difficile Infection(CDI) in Solid Organ Transplant Recipients (SOTR).
Y. Natori, M. Shiotsuka, L. Oen, E. Renner, L. Singer, H. Ross, D. Kumar, C. Rotstein, A. Humar, S. Husain.
Multi-Organ Transplant, University Health Network, Toronto, ON, Canada.
Introduction: CDI is one of the most common infections among SOTR, and is associated with significant morbidity and mortality. However, the data regarding early vs.…
2016 American Transplant Congress
Storage Kidneys Prior to Transplantation Using First Polish Preservation Solution "Biolasol" – Preliminary Report.
A. Jozwik,¹ P. Domagala,¹ R. Kieszek,¹ M. Wszola,¹ M. Bieniasz,¹ M. Serwanska-Swietek,¹ M. Durlik,² F. Ryszka,³ A. Chmura,¹ A. Kwiatkowski.¹
¹Department of General Surgery and Transplantology, Medical University of Warsaw, Warsaw, Poland; ²Departments of Transplantology and Nephrology, Medical University of Warsaw, Warsaw, Poland; ³BIOCHEFA, Sosnowiec, Poland.
One of the factors affecting function of the transplanted organ is a method of its storage. The aim of the study is to evaluate the…
2016 American Transplant Congress
Incidence of Infectious Disease and Malignancies After Rituximab Therapy in Kidney-Transplant Recipients.
E. Schrezenmeier,¹ T. Doerner,² O. Staeck,¹ K. Budde,¹ F. Halleck.¹
¹Nephrology, Charité, Berin, Germany; ²Rheumatology, Charité, Berlin, Germany.
BACKGROUND:Rituximab off-label use is common in solid organ transplantation. It is used in patients with antibody-mediated rejections, in AB0-incompatible renal transplantation, in pre-sensitized organ recipients…
2016 American Transplant Congress
The Effect of Bortezomib on DSA Reduction During the Treatment of AMR in Pediatric Kidney Transplant Patients.
O. Moussa, S. Self, K. Twombley.
Medical University of South Carolina, Charleston, SC.
Introduction: The optimal therapy for AMR is not well defined in children or adults. AMR carries a worse prognosis than ACR and can lead to…
2016 American Transplant Congress
Association of Smoking Habits with Comorbidity 15 Years After Liver Transplantation.
S. Pischke,³ M. Lege,¹ L. Fischer,² U. Herden,² A. Lohse,³ B. Nashan,² M. Sterneck.¹
¹University Transplant Center, University Hospital Hamburg Eppendorf, Hamburg, Germany; ²Department of Hepatobiliary Surgery and Transplantation, University Hospital Hamburg Eppendorf, Hamburg, Germany; ³Department of Medicine, University Hospital Hamburg Eppendorf, Hamburg, Germany.
Background and aimsThe survival rate of liver transplant (OLT) recipients has strongly improved over the last years. Here we investigate the association between long term…
2016 American Transplant Congress
Can OPTN/UNOS Policies Be Effectively Transferred to Another Country's Healthcare System? Russian Case.
B. Yaremin,¹ A. Mironov,⁴ A. Kolsanov,² A. Navasardyan,¹ R. Akhmetshin,³ A. Starostina.²
¹Samara Regional Ministry of Health, Samara, Russian Federation; ²Operative Surgery Chair, Samara State Medical University, Samara, Russian Federation; ³Moscow Regional Ministry of Health, Moscow, Russian Federation; ⁴Samara Organ Procurement Organisation, Samara State Medical University, Samara, Russian Federation.
US Organ Procurement System known as one of the most advanced systems all over the World. Start of new transplant program in other country always…
2016 American Transplant Congress
Living Donor Liver Transplantation for Children With Biliary Atresia in the Pediatric End-Stage Liver Disease Era: The Role of Age and Insurance Status.
J. Chu,^1,2 R. Annunziato,³ R. Aviles,³ R. Arnon.^1,2
¹Pediatrics, Mount Sinai Medical Center, NY, NY; ²Recanati/Miller Transplantation Institute, Mount Sinai Medical Center, NY, NY; ³Psychology, Fordham University, Bronx, NY.
Lower socioeconomic status has been linked to inferior health outcomes. We have previously shown that children with biliary atresia (BA) who have public insurance (PU)…
2016 American Transplant Congress
Neutrophil-to-Lymphocyte Ratio as a Predictor of Polyomavirus BK Nephropathy in Kidney Transplant Patients.
K. Masutani,¹ A. Tsuchimoto,¹ Y. Matsukuma,¹ K. Kaku,² K. Kurihara,² Y. Okabe,² K. Tsuruya,¹ M. Nakamura,² T. Kitazono.¹
¹Department of Medicine and Clinical Science, Kyushu University, Fukuoka, Japan; ²Department of Surgery and Oncology, Kyushu University, Fukuoka, Japan.
Background: Neutrophil-to-lymphocyte ratio (NLR) is an index for systemic inflammatory response, and has been reported to be a prognostic marker in the patients with malignancies…
2016 American Transplant Congress
Comparison of Efficacy of Different Regimens for Treating Recurrent IgA Nephropathy After Kidney Transplantation.
G. Chen, C. Wang, L. Chen, J. Qiu, C. Wang, J. Fei, S. Deng, J. Li, G. Huang, Q. Fu.
Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Background Recurrent IgA nephropathy is a common complication after kidney transplantation. How to treat recipients with recurrent IgA nephropathy is still controversial. There are two…
2016 American Transplant Congress
Long-Term Renal Allograft Outcome After Parathyroidectomy.
M. Patecki, I. Scheffner, H. Haller, W. Gwinner.
Medical School Hannover, Hannover, Germany.
Parathyroidectomy (PTx) after kidney transplantation (Tx) has been reported to have adverse effects on the allograft. In this study, we analyzed the course of patients…